Brenipatide for Substance Use Disorders: Current Evidence at a Glance (September 2026)
Source:https://sin-adiccion.blogspot.com/2026/09/brenipatide-brenipatida.html
Given the current state of the evidence, brenipatide should not replace approved or guideline-recommended treatments for alcohol, opioid, or tobacco use disorders outside the context of a clinical trial.
References / Referencias
- Cai, M., Choi, T., Xie, Y., & Al-Aly, Z. (2026). Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: Cohort study. BMJ, 392, e086886. https://doi.org/10.1136/bmj-2025-086886 [pubmed.ncb...lm.nih.gov]
- Patil, S., Jha, N...